Who
Jennifer A. Doudna
Director
Company insider
Files Form 4 as: Director, Tempus AI; 10% owner, Scribe Therapeutics; Director, Johnson & Johnson.
In numbers
- Trades disclosed
- 36
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $1.5M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 12 Feb 2019
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $44K676 at $65.55 | filing |
| 1 Sep 2026filed 3 Sep 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $44K676 at $65.55 | filing |
| 27 Jul 2026filed 29 Jul 2026 | SCTX Scribe TherapeuticsBiotechnology | SEC FORM 4 Code C | —12,511 | filing |
| 27 Jul 2026filed 29 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —74,088 | filing |
| 27 Jul 2026filed 29 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —74,088 | filing |
| 27 Jul 2026filed 29 Jul 2026 | SCTX Scribe TherapeuticsBiotechnology | SEC FORM 4 Code C | —12,511 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $147K2,673 at $55.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $147K2,673 at $55.00 | filing |
| 21 May 2026filed 26 May 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Code A | —5,913 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Code A | —5,913 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —975 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —975 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $75K1,250 at $60.17 | filing |
| 2 Jan 2026filed 6 Jan 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $75K1,250 at $60.17 | filing |
| 1 Dec 2025filed 3 Dec 2025 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $51K676 at $75.55 | filing |
| 11 Nov 2025filed 13 Nov 2025 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $138K1,926 at $71.45 | filing |
| 1 Jul 2025filed 3 Jul 2025 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $39K625 at $62.52 | filing |
| 2 Jun 2025filed 4 Jun 2025 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $31K558 at $55.20 | filing |
| 20 May 2025filed 22 May 2025 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Code A | —1,997 at $0.00 | filing |
| 24 Apr 2025filed 28 Apr 2025 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,316 at $0.00 | filing |
News
Tempus AI (NASDAQ:TEM) Stock Gets Price Target Bump from JPMorgan Chase & Co.TEM · dailypolitical.com · 14 Oct 2026Analyzing 111 (NASDAQ:YI) & Tempus AI (NASDAQ:TEM)TEM · themarketsdaily.com · 13 Oct 2026Tempus AI (NASDAQ:TEM) Stock Price Target Raised at Canaccord Genuity GroupTEM · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Jennifer A. Doudna; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.